← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 2, 1999Last known activity
May 1, 2011
Acquired by Aviragen Therapeutics → Vaxart on Apr 23, 2012
Timeline
1960s
- Jan 1, 1967
Nabi Biopharmaceuticals— Founded
1990s
- Nov 29, 1995
Univax Biologics Inc— Acquired
2010s
- Apr 23, 2012
Aviragen Therapeutics— Acquired By
- Oct 30, 2017
Vaxart— Now
Drugs by trial phase (15 distinct, 23 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (1 own, 1 via acquisition)
Indications
Studied for
- Arteriosclerosis
- Bacteremia
- Birth Weight
- Calcinosis
- Cardiovascular Diseases
- HIV Infections
- Hyperparathyroidism
- Hyperparathyroidism, Secondary
- Hyperphosphatemia
- Infections
- Kidney Diseases
- Kidney Failure, Chronic
- Recurrence
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Staphylococcal Infections
- Tobacco Use Disorder
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (37)
- NCT01375933Study directorPhase 3May 1, 2011
- NCT01375933Lead sponsorPhase 3May 1, 2011
- NCT01178346Lead sponsorPhase 3Jul 1, 2010
- NCT01178346Study directorPhase 3Jul 1, 2010
- NCT01102114Study directorPhase 3Mar 1, 2010
- NCT01102114Lead sponsorPhase 3Mar 1, 2010
- NCT01011335CollaboratorPhase 1/Phase 2Nov 1, 2009
- NCT01011335Overall official - principal investigatorPhase 1/Phase 2Nov 1, 2009
- NCT00836199Study directorPhase 3Oct 1, 2009
- NCT00995033CollaboratorPhase 2Oct 1, 2009
- NCT00836199Lead sponsorPhase 3Oct 1, 2009
- NCT00996034CollaboratorPhase 2Sep 1, 2009
- NCT00598325Lead sponsorPhase 1/Phase 2Jan 1, 2008
- NCT00598325Study directorPhase 1/Phase 2Jan 1, 2008
- NCT00318383Study directorPhase 2May 1, 2006
Details
- Founded
- Rockville, MD, US Jan 1, 1967
- Last known activity
- May 1, 2011
Notes
--- Pre-folding founded info: 1996-01-01 Rockville MD US https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=182949 ---